Local treatment strategies in Stage IVB cervical squamous cell carcinoma and adenocarcinoma

医学 放射治疗 腺癌 宫颈癌 阶段(地层学) 内科学 肿瘤科 倾向得分匹配 比例危险模型 胃肠病学 外科 癌症 古生物学 生物
作者
Jingying Xu,Min Hu,San‐Gang Wu,Juan Zhou
出处
期刊:International journal of gynaecology and obstetrics [Wiley]
标识
DOI:10.1002/ijgo.15121
摘要

To evaluate the effect of different local treatment strategies on survival outcomes in patients with Stage IVB cervical squamous cell carcinoma (SCC) and adenocarcinoma.Patients diagnosed with Stage IVB cervical SCC and adenocarcinoma between 2004 and 2015 were included from the Surveillance, Epidemiology, and End Results (SEER) database. Subgroup analysis was performed in those diagnosed between 2010 and 2015 and available for the sites of distant metastases.In total, 706 patients were identified in this study, including 378 (53.5%) and 328 (46.5%) diagnosed in 2004-2009 and 2010-2015, respectively. There were 525 (74.4%) and 181 (25.6%) patients with SCC and adenocarcinoma, respectively. Moreover, 274 (38.8%) and 432 (61.2%) patients received hysterectomy and primary radiotherapy, respectively. The results of the multivariate Cox regression analysis showed that histology and local treatment strategies were not related to cause-specific survival (CSS) and overall survival. In the SCC patients, patients who received primary radiotherapy had similar CSS (P = 0.312) and overall survival (P = 0.390) compared with those treated with surgery. In the adenocarcinoma patients, those who received primary radiotherapy had inferior CSS (P = 0.003) and overall survival (P < 0.001) compared with those treated with surgery. Similar results were found in those diagnosed 2004-2015 and 2010-2015 after propensity score matching.For patients with Stage IVB cervical cancer who received local therapy, surgery, and primary radiotherapy had similar survival in cervical SCC, whereas surgery had better survival outcomes compared with primary radiotherapy in those with cervical adenocarcinoma.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LUNWENREQUEST发布了新的文献求助10
刚刚
大模型应助匹诺曹采纳,获得10
1秒前
ding应助过时的又槐采纳,获得10
2秒前
5秒前
鄙视注册完成签到,获得积分10
6秒前
6秒前
7秒前
7秒前
落寞溪灵完成签到 ,获得积分10
9秒前
玖玖柒idol完成签到,获得积分10
9秒前
曌虞完成签到,获得积分10
9秒前
10秒前
啥,这都是啥完成签到,获得积分10
10秒前
皮皮桂发布了新的文献求助10
11秒前
12秒前
大大发布了新的文献求助10
12秒前
13秒前
orixero应助wang1090采纳,获得30
15秒前
15秒前
l11x29发布了新的文献求助10
17秒前
lin完成签到,获得积分10
17秒前
大侠发布了新的文献求助10
18秒前
18秒前
是锦锦呀完成签到,获得积分10
18秒前
18秒前
李秋静发布了新的文献求助10
19秒前
zhen发布了新的文献求助50
21秒前
是锦锦呀发布了新的文献求助60
21秒前
Khr1stINK发布了新的文献求助10
23秒前
24秒前
NexusExplorer应助Dddd采纳,获得10
26秒前
26秒前
Akim应助zhaowenxian采纳,获得10
27秒前
谦让的鹏煊完成签到,获得积分10
28秒前
zccc完成签到 ,获得积分10
29秒前
30秒前
hhzz发布了新的文献求助10
31秒前
坚定的雁完成签到 ,获得积分10
32秒前
33秒前
两先生完成签到 ,获得积分10
33秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527961
求助须知:如何正确求助?哪些是违规求助? 3108159
关于积分的说明 9287825
捐赠科研通 2805882
什么是DOI,文献DOI怎么找? 1540070
邀请新用户注册赠送积分活动 716926
科研通“疑难数据库(出版商)”最低求助积分说明 709808